These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 16153440

  • 21. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
    Glienke W, Maute L, Wicht J, Bergmann L.
    Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
    [Abstract] [Full Text] [Related]

  • 22. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B, Liu X, Fan J, Qi R, Bo L, Gu J, Qian Q, Qian C, Liu X.
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [Abstract] [Full Text] [Related]

  • 23. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
    Gu L, Chiang KY, Zhu N, Findley HW, Zhou M.
    Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
    [Abstract] [Full Text] [Related]

  • 24. Construction of survivin siRNA expression vector and its regulation on cell cycle and proliferation in MCF-7 cells.
    Li LP, Liang NC, Luo CQ.
    Ai Zheng; 2004 Jul; 23(7):742-8. PubMed ID: 15248905
    [Abstract] [Full Text] [Related]

  • 25. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA.
    Cheng B, Yang X, Han Z, An L, Liu S.
    Auris Nasus Larynx; 2008 Mar; 35(1):95-101. PubMed ID: 17869043
    [Abstract] [Full Text] [Related]

  • 26. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
    Warnecke-Eberz U, Hokita S, Xi H, Higashi H, Baldus SE, Metzger R, Brabender J, Bollschweiler E, Mueller RP, Dienes HP, Hoelscher AH, Schneider PM.
    Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.
    Nakao K, Hamasaki K, Ichikawa T, Arima K, Eguchi K, Ishii N.
    Oncol Rep; 2006 Aug; 16(2):389-92. PubMed ID: 16820920
    [Abstract] [Full Text] [Related]

  • 32. Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation.
    Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Haraguchi N, Inoue H, Murayama S, Mori M.
    Int J Oncol; 2006 Mar; 28(3):705-13. PubMed ID: 16465376
    [Abstract] [Full Text] [Related]

  • 33. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells.
    Chen T, Deng C.
    Int Immunopharmacol; 2008 Jul; 8(7):1006-11. PubMed ID: 18486912
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N, Hill AD, Young LS.
    J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
    [Abstract] [Full Text] [Related]

  • 37. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.
    Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018
    [Abstract] [Full Text] [Related]

  • 38. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
    Sakoguchi-Okada N, Takahashi-Yanaga F, Fukada K, Shiraishi F, Taba Y, Miwa Y, Morimoto S, Iida M, Sasaguri T.
    Biochem Pharmacol; 2007 May 01; 73(9):1318-29. PubMed ID: 17270149
    [Abstract] [Full Text] [Related]

  • 39. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
    Pennati M, Binda M, Colella G, Zoppe' M, Folini M, Vignati S, Valentini A, Citti L, De Cesare M, Pratesi G, Giacca M, Daidone MG, Zaffaroni N.
    Oncogene; 2004 Jan 15; 23(2):386-94. PubMed ID: 14724567
    [Abstract] [Full Text] [Related]

  • 40. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF.
    Mol Cell Biol; 2007 Nov 15; 27(21):7703-17. PubMed ID: 17785436
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.